Ravasio R, Rigo F, Lattuada E, Concia E, Lanzafame M. The cost of a combination Anti-Retroviral Therapy (cART) optimization pathway as maintenance therapy in HIV-1 infected patients. FE [Internet]. 2017 Nov. 6 [cited 2025 Jul. 23];18(1). Available from: https://provafe.seedstm.com/index.php/FE/article/view/1325